Document Detail


Defining the Role of Lipoprotein Apheresis in the Management of Familial Hypercholesterolemia.
MedLine Citation:
PMID:  22011648     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Familial hypercholesterolemia (FH) is an autosomal co-dominant disorder characterized by a marked elevation of serum low-density lipoprotein (LDL) cholesterol (LDL-C) concentration, which in turn is associated with a greatly increased risk of premature cardiovascular disease. International consensus recommends the use of statins as the first line of treatment for patients with this condition. However, homozygote FH patients with persistently elevated LDL-C levels are usually resistant to multiple-drug therapy. Fortunately, LDL apheresis (or simply 'lipoprotein apheresis') provides a treatment option for patients who are refractory or intolerant to lipid-lowering medications, or if there is progressive cardiovascular disease despite maximal drug therapy.Lipoprotein apheresis is an extracorporeal LDL-C-lowering treatment similar in concept to renal dialysis. There are now five main methods for extracorporeal lipoprotein apheresis in use, namely dextran sulfate adsorption (DSA), heparin extracorporeal LDL precipitation (HELP), polyacrylate full blood adsorption (PFBA or DALI system) using hemoperfusion, immunoadsorption, and filtration plasmapheresis.Lipoprotein apheresis has been shown to be successful in reducing LDL-C levels, as well as levels of lipoprotein(a) [Lp(a)], a prothrombotic proatherogenic lipoprotein. In contrast, however, lipoprotein apheresis seems to have a smaller effect in preventing atherosclerosis progression, thus suggesting that a major component of the reduction in cardiovascular events may be mediated by mitigating Lp(a) levels. Side effects are infrequent and mild, and have mainly consisted of lightheadedness, nausea, vomiting, and hypotension. As these are often bradykinin-mediated and associated with concomitant ACE inhibitor use, angiotensin type 2 receptor antagonists should be used instead of ACE inhibitors with DALI and PFBA. Nevertheless, there is scope for wider application of lipoprotein apheresis.The high cost and invasive nature of lipoprotein apheresis limits uptake; however, it is an important treatment modality that should be considered in carefully selected patients. National and international registries compiling outcome data for lipoprotein apheresis need to be established to help expand the evidence base regarding its effectiveness.
Authors:
Wai Ping Lee; Borunendra N Datta; Beng Beng Ong; Alan Rees; Julian Halcox
Related Documents :
16826508 - Metabolism of dietary cetoleic acid (22:1n-11) in mink (mustela vison) and gray seals (...
20514048 - Zinc-α2-glycoprotein: an adipokine modulator of body fat mass?
17823448 - Conjugated linoleic acid supplementation alters the 6-mo change in fat oxidation during...
19029198 - Effects of a high-fat, low- versus high-glycemic index diet: retardation of insulin res...
8022898 - Serotoninergic modulation of sodium appetite in the rat.
10827018 - Whole body and abdominal lipolytic sensitivity to epinephrine is suppressed in upper bo...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-10-18
Journal Detail:
Title:  American journal of cardiovascular drugs : drugs, devices, and other interventions     Volume:  -     ISSN:  1179-187X     ISO Abbreviation:  -     Publication Date:  2011 Oct 
Date Detail:
Created Date:  2011-10-20     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100967755     Medline TA:  Am J Cardiovasc Drugs     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
University Hospital Wales, Cardiff University, Cardiff, Wales, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Vulnerability to high risk sexual behaviour (HRSB) following exposure to war trauma as seen in post-...
Next Document:  Gene Copy Number Aberrations Are Associated with Survival in Histologic Subgroups of Non-small Cell ...